The management of retinoblastoma is challenging and complex. Preservation of the eyeball as well as vision, with minimum morbidity, is the aim in the initial stages. This has been made possible by the use of chemotherapy that is targeted to the eye in the form of selective intravitreal and intra-arterial chemotherapy which has shown promising results. The efficacy and safety of intra- arterial chemotherapy have been reported by many specialized centers. The aim of this article was to review the role of intraarterial chemotherapy in the management of retinoblastoma and its clinical outcomes. In addition, we will review the possible complications of the procedure. We were able to collect articles relevant to our research objectives by reviewing the title and abstract of each article. Irrelevant articles and those that did not meet the inclusion criteria were excluded. This yielded a total of 19 studies. The results indicated that intraarterial chemotherapy is an effective and new modality of treatment for retinoblastoma to salvage the eyeball and helps in the prevention of enucleation with minimal local and systemic complications that are mostly transient. For future work, we recommend conducting more prospective studies with large samples and the long duration of follow-up. Also, we recommend future studies focusing on assessing visual acuity, as most of the currently available studies did not assess the visual acuity, making the judgment on vision preservation with IAC difficult.
References
[1]
Pekacka, A. (2020) The Role of Intraarterial Chemotherapy in the Management of Retinoblastoma. Journal of Ophthalmology, 2020, Article ID: 3638410. https://doi.org/10.1155/2020/3638410
[2]
Isidro, M. (2019) Retinoblastoma: Background, Pathophysiology, Epidemiology. https://emedicine.medscape.com/article/1222849-overview
[3]
Chawla, B. and Singh, R. (2017) Recent Advances and Challenges in the Management of Retinoblastoma. Indian Journal of Ophthalmology, 65, 133-139. https://doi.org/10.4103/ijo.IJO_883_16
[4]
Chen, M., Jiang, H., Zhang, J., Shen, G., Jiang, Y., Li, H. and Liu, Z. (2017) Outcome of Intra-Arterial Chemotherapy for Retinoblastoma and Its Influencing Factors: A Retrospective Study. Acta Ophthalmologica, 95, 613-618. https://doi.org/10.1111/aos.13333
[5]
Kim, J. and Berry, J. (2021) Retinoblastoma: Clinical Presentation, Evaluation, and Diagnosis. https://www.uptodate.com/contents/retinoblastoma-clinical-presentation-evaluation-and-diagnosis
[6]
Murray, T. and Villegas, V. (2021) Retinoblastoma. https://bestpractice.bmj.com/topics/en-us/1055
[7]
Novetsky, D., Abramson, D., Kim, J. and Dunkel, I. (2009) Published International Classification of Retinoblastoma (ICRB) Definitions Contain Inconsistencies—An Analysis of Impact. Ophthalmic Genetics, 30, 40-44. https://doi.org/10.1080/13816810802452168
[8]
Manjandavida, F., Stathopoulos, C., Zhang, J., Honavar, S. and Shields, C. (2019) Intra-Arterial Chemotherapy in Retinoblastoma—A Paradigm Change. Indian Journal of Ophthalmology, 67, 740. https://doi.org/10.4103/ijo.IJO_866_19
[9]
Levin, M., Kim, J. and Klufas, M. (2019) Intra-Arterial Chemotherapy for Retinoblastoma. https://eyewiki.aao.org/Intra-arterial_Chemotherapy_for_Retinoblastoma#Indications
[10]
Liu, C.C., Mohmood, A., Hamzah, N., Lau, J.H., Khaliddin, N. and Rahmat, J. (2020) Intra-Arterial Chemotherapy for Retinoblastoma: Our First Three-and-a-Half Years’ Experience in Malaysia. PLoS ONE, 15, e0232249. https://doi.org/10.1371/journal.pone.0232249
[11]
Rishi, P., Sharma, T., Koundanya, V., Bansal, N., Saravanan, M., Ravikumar, R. and Ramamurthy, S. (2015) Intra-Arterial Chemotherapy for Retinoblastoma: First Indian Report. Indian Journal of Ophthalmology, 63, 331-334. https://doi.org/10.4103/0301-4738.158076
[12]
Khaqan, H.A., Imtiaz, U., Ateeq-ur-Rehman and Rasheed, U. (2020) Experience of Selective Intra-Arterial Chemotherapy for Retinoblastoma. The Journal of the Pakistan Medical Association, 70, 178-182.
[13]
Chen, Q., Zhang, B., Dong, Y., Mo, X., Zhang, L., Xia, J., Zhang, J. and Zhang, S. (2020) Evaluating Primary Intra-Arterial Chemotherapy versus Intravenous plus Intra-Arterial Chemotherapy for Advanced Intraocular Retinoblastoma. Cancer Chemotherapy and Pharmacology, 85, 723-730. https://doi.org/10.1007/s00280-020-04036-w
[14]
Hutchinson, A., Kaliki, S. and Shields, C.L. (2012) Two-Dose Exposure of Intra-Arterial Chemotherapy for Group D Retinoblastoma. Journal of Pediatric Ophthalmology and Strabismus, 49, e15-e18. https://doi.org/10.3928/01913913-20120320-01
[15]
Rishi, P., Agarwal, A., Chatterjee, P., Sharma, T., Sharma, M., Saravanan, M. and Ravikumar, R. (2020) Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India. Ocular Oncology and Pathology, 6, 66-73. https://doi.org/10.1159/000500010
[16]
Gobin, Y.P., Dunkel, I.J., Marr, B.P., Brodie, S.E. and Abramson, D.H. (2011) Intra-Arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience. Archives of Ophthalmology (Chicago, Ill.: 1960), 129, 732-737. https://doi.org/10.1001/archophthalmol.2011.5
[17]
Funes, S., Sampor, C., Villasante, F., Fandiño, A., Manzitti, J., Sgroi, M., Neira, P., Peralta, L., Lagomarsino, E., Schaiquevich, P., Ceciliano, A. and Chantada, G.L. (2018) Feasibility and Results of an Intraarterial Chemotherapy Program for the Conservative Treatment of Retinoblastoma in Argentina. Pediatric Blood & Cancer, 65, e27086. https://doi.org/10.1002/pbc.27086
[18]
Shields, C. (2011) Intra-Arterial Chemotherapy for Retinoblastoma. Archives of Ophthalmology, 129, 1407. https://doi.org/10.1001/archophthalmol.2011.151
[19]
Rojanaporn, D., Chanthanaphak, E., Boonyaopas, R., Sujirakul, T., Hongeng, S. and Ayudhaya, S. (2019) Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand. Asia-Pacific Journal of Ophthalmology, 8, 211-217.
[20]
Chen, M., Zhao, J., Xia, J., Liu, Z., Jiang, H., Shen, G., Li, H., Jiang, Y. and Zhang, J. (2016) Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies. PLoS ONE, 11, e0160873. https://doi.org/10.1371/journal.pone.0160873
Abramson, D.H., Marr, B.P., Brodie, S.E., Dunkel, I., Palioura, S. and Gobin, Y.P. (2012) Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review. PLoS ONE, 7, e34120. https://doi.org/10.1371/journal.pone.0034120
[23]
Akyüz, C., Kıratlı, H., Şen, H., Aydın, B., Tarlan, B. and Varan, A. (2015) Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience. Ophthalmologica, 234, 227-232. https://doi.org/10.1159/000439357
[24]
Rishi, P., Sharma, T., Sharma, M., Maitray, A., Dhami, A., Aggarwal, V., Munusamy, S., Ravikumar, R. and Ramamurthy, S. (2017) Intra-Arterial Chemotherapy for Retinoblastoma: Two-Year Results from Tertiary Eye-Care Center in India. Indian Journal of Ophthalmology, 65, 311-315. https://doi.org/10.4103/ijo.IJO_843_16
[25]
Tuncer, S., Sencer, S., Kebudi, R., Tanyıldız, B., Cebeci, Z. and Aydın, K. (2016) Super-selective Intra-Arterial Chemotherapy in the Primary Management of Advanced Intra-Ocular Retinoblastoma: First 4-Year Experience from a Single Institution in Turkey. Acta Ophthalmologica, 94, e644-e651. https://doi.org/10.1111/aos.13077
[26]
Abramson, D.H., Daniels, A.B., Marr, B.P., Francis, J.H., Brodie, S.E., Dunkel, I.J. and Gobin, Y.P. (2016) Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. PLoS ONE, 11, e0146582. https://doi.org/10.1371/journal.pone.0146582
[27]
Selzer, E.B., Welch, R.J., Jabbour, P., Leahey, A.M. and Shields, C.L. (2019) Management of Retinoblastoma in Older Children (>5 Years) Using Intra-Arterial Chemotherapy: Comparison of Outcomes to Prechemotherapy and Intravenous Chemotherapy Eras. Indian Journal of Ophthalmology, 67, 2005-2011. https://doi.org/10.4103/ijo.IJO_642_19
